All Outputs (2)

Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study (2021)
Journal Article
Schober, K., Rush, J., Fuentes, V., Glaus, T., Summerfield, N., Wright, K., Lehmkuhl, L., Wess, G., Sayer, M., Loureiro, J., MacGregor, J., & Mohren, N. (2021). Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study. Journal of Internal Medicine, 35(2), 789-800. https://doi.org/10.1111/jvim.16054

Background The benefits of pimobendan in the treatment of congestive heart failure (CHF) in cats with hypertrophic cardiomyopathy (HCM) have not been evaluated prospectively. Hypothesis/Objectives To investigate the effects of pimobendan in cats with... Read More about Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study.

Immunohistological Evaluation Of Von Willebrand Factor In The Left Atrial Endocardium And Atrial Thrombi From Cats With Cardiomyopathy (2021)
Journal Article
Connolly, D., Wan-Ching, C., Wilkie, L., Anne Kurosawa, T., Dobromylskyj, M., Lawrence Priestnall, S., & Luis Fuentes, V. (2021). Immunohistological Evaluation Of Von Willebrand Factor In The Left Atrial Endocardium And Atrial Thrombi From Cats With Cardiomyopathy. Animals, https://doi.org/10.3390/ani11051240